Orthocell Ltd makes progress with portfolio of CelGro® products within the bone tendon and nerve space proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.
)
Orthocell’s breakthrough tissue engineering study with CelGro® to create functional lymphatic tissue published in PNAS
The findings represent a substantial advance in the ex vivo fabrication of implantable lymphatic grafts and their use in novel surgical treatments for patients suffering from lymphedema. The research opens up potential for novel treatments addressing significant unmet medical needs in women’s health.
Orthocell Ltd (ASX:OCC)’s breakthrough tissue engineering study, combining CelGro® with lymphatic and blood vessel cells to create functional lymphatic tissue, has been published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS).
Orthocell Ltd s breakthrough tissue engineering study with CelGro® to create functional lymphatic tissue published in PNAS proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.
Perth programme and bid attracts Neuromuscular Congress to return to Western Australia in 2024
The International Congress on Neuromuscular Diseases is set to return to
Perth, Western Australia, for the first time in over 50 years. The Congress is expected to attract thousands of delegates from around the world for the 2024 date.
The event was first held in Perth in 1971, following the groundbreaking research by Western Australian (WA) Emeritus Professor Byron Kakulas AO who showed that degenerated muscle could regenerate in quokkas.
This research eventually led to United States Food and Drug Administration approved treatments developed by WA’s Perron Institute for Neurological and Translational Science for Duchenne muscular dystrophy, with application to other diseases.